{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01133",
      "entity_text" : "EGF",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00239",
      "entity_text" : "Cetuximab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Cetuximab interacts strongly and competitively with EGFR, blocking the binding of its natural ligand EGF and transforming growth factor alpha (TGFalpha), causing receptor internalization XREF_BIBR, XREF_BIBR.",
  "reading_complete" : "2020-08-02T07:37:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T07:36:31Z",
  "trigger" : "blocking",
  "evidence" : [ "Cetuximab interacts strongly and competitively with EGFR, blocking the binding of its natural ligand EGF" ],
  "pmc_id" : "6531304",
  "score" : 0
}